News

Under the terms of the agreement, which is contingent upon completion of the sale of Savient’s global biologics manufacturing business to Ferring BV and Ferring International Centre SA,

Impavido (miltefosine) has been approved to treat the cutaneous form of leishmaniasis, a severe parasitic skin disease estimated to affect millions of people worldwide. This is the first-ever

This achievement solidifies Schering-Plough Corporation’s long-standing leadership position of successfully converting prescription products into major over-the-counter (OTC) brands, as a core marketing strategy for extending the lifecycle of

Pharmacogenomics allows health care providers to identify sources of an individual’s profile of drug response and predict the best possible treatment option for this individual. For example, genomic

In the first study, conducted in patients aged 12 years and older, researchers concluded that treatment taken once a day with Alvesco (ciclesonide) significantly improves quality-of-life in patients

As a result of its decision, Bristol-Myers Squibb will continue to provide to AIDS drug assistance programs (ADAPs) during the next two years by supplying its complete line

The primary objective of the three-arm phase I clinical trial is to determine the safety and tolerability of different dosages and routes of administration of the DNA vaccine,

The trial’s primary endpoint was to reduce hemoglobin A1c (HbA1c). The proof-of-principle trial demonstrated that metaglidasen had comparable efficacy to currently marketed insulin sensitizers without causing the dose-limiting

The companies have begun work on developing a product that could be used to select the most appropriate drug and dosage for patients treated for psychiatric diseases. Although